Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
5
VanEck Oil Services ETF
OIH
US Stock MarketDetailed Quotes
NOVARTIS AG (NVSEF)
- 153.650
- -6.350-3.97%
15min DelayClose Jul 10 13:14 ET
293.18BMarket Cap22.01P/E (TTM)
153.650High152.640Low1.65KVolume152.640Open160.000Prev Close253.54KTurnover0.00%Turnover Ratio21.49P/E (Static)1.91BShares167.29152wk High7.61P/B292.94BFloat Cap108.15552wk Low4.63Dividend TTM1.91BShs Float167.291Historical High3.01%Div Yield TTM0.63%Range %63.181Historical Low153.474Avg Price1Lot Size
About NOVARTIS AG Company
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
Company Profile
SymbolNVSEF
Company NameNOVARTIS AG
Listing DateMay 11, 2000
ISINUS66987V1098
Founded1996
CEODr. Vasant Narasimhan
MarketPink Market
Employees75267
Fiscal Year Ends12-31
AddressLichtstrasse 35
CityBasel
ProvinceBasel-Stadt (Basle Town)
CountrySwitzerland
Zip Code4056
Phone41-61-324-11-11
Websitehttp://www.novartis.com
Company Executives
- Name
- Position
- Salary
- Dr. Vasant Narasimhan
- Chief Executive Officer
- 15.19M
- Karen L. Hale
- Chief Legal and Compliance Officer
- --
- Robert Kowalski
- Chief People and Organization Officer
- --
- Harry Kirsch
- Chief Financial Officer
- 6.00M
- Dr. Shreeram Aradhye, M.D.
- President, Development and Chief Medical Officer
- --
- Dr. Aharon Gal, PhD
- Chief Strategy and Growth Officer
- --
- Simon E Moroney, D.Phil.
- Vice Chairman of the Board
- 460.00K
- Carulla Victor Bulto
- President, US
- 5.75M
- Dr. Steffen Lang, PhD
- President, Operations
- --
- Dr. Patrick Horber, M.D.
- President, International
- 5.63M
- Dr. Giovanni Caforio, M.D.
- Chairman of the Board
- 2.94M
- Dr. Fiona H. Marshall, PhD
- President, Biomedical Research
- --
- Elizabeth McNally, M.D.,PhD
- Director
- 266.67K
- Elizabeth Doherty
- Independent Director
- 450.00K
- Bridgette P. Heller
- Independent Director
- 430.00K
- Ana de Pro Gonzalo
- Independent Director
- 390.00K
- Ton Buechner
- Independent Director
- 424.81K
- Patrice Bula
- Lead Independent Director
- 413.92K
- John Douglas Young
- Independent Director
- 423.33K
- Frans Van Van Houten, M.Sc.
- Independent Director
- 423.33K
- Daniel Hochstrasser
- Independent Director
- 394.14K
- Dr. Nancy C. Andrews, M.D.,PhD
- Independent Director
- 360.00K
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
On July 8, Eastern Time, U.S. forces launched a new round of strikes against Iran aimed at degrading Iran's ability to threaten freedom of n
牛牛課堂
Jun 15 14:46
美伊和平曙光初現！全球市場「拆彈式狂歡」：誰在帶頭衝鋒，升势還能跑多遠？
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.